141.00
+3.71%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Vaidya Sane Ayurved Laboratories
Its shares trade on NSE under the ticker MADHAVBAUG.NS. It has been listed since 23 February 2022. In the fiscal year to 31 March 2025, it reported revenue of ₹898.5m and net income of ₹71.4m. At that date it held total assets of ₹767.1m and shareholders' equity of ₹625.4m.
Vaidya Sane Ayurved Laboratories Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Thane, Maharashtra. The company went IPO on 2022-02-23. Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The firm is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. The company uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The firm operates approximately 337 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Haryana, Punjab, Himachal Pradesh, Uttarakhand, West Bengal, Jammu, Kerala, Orissa and Chhattisgarh. The company owns about 55 clinics, 59 are OPD's and Mini Clinic and 223 are franchise clinics. The firm operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 23 Feb 2022
- Employees
- 632
Leadership
Pay as last reported
- Dr. Rohit SaneChief Executive Officer, Managing Director, Executive Director, since 2021₹6.0m
- Mr. Narendra PawarChief Financial Officer₹1.2m
- Mr. Yogesh WalawalkarChief Strategy Officer, Senior Vice President of Marketing₹2.8m
- Ms. Vidyut GhagWhole Time Director, since 2021₹2.0m
- Dr. Gurudatta AminChief Medical Officer₹2.5m
- Dr. Sushrut DambalIndependent Director₹210,000
- Dr. Mahesh KshirsagarIndependent Director₹210,000
- Mr. Ratnakar RaiIndependent Director₹210,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates 337 clinics across multiple Indian states including Maharashtra and Gujarat
- Owns 55 clinics and has 59 OPD's and Mini Clinics
- Provides ayurvedic treatments for heart disease, diabetes, hypertension, and obesity
Weaknesses
- Limited to ayurvedic medicine and treatments only
- Relies on franchise model for 223 clinics which may affect service consistency
- Operates in a niche healthcare sector with limited market diversification
Opportunities
- Expanding into new states not currently covered by their clinics
- Increasing demand for ayurvedic medicine in India and globally
- Potential for partnerships with diagnostic centers to enhance service offerings
Threats
- Competition from conventional healthcare providers in the same market
- Regulatory challenges specific to ayurvedic medicine practices
- Dependence on a single industry sector (ayurvedic healthcare)
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.